As of Feb 03, 2025, Apple Relative Value is $371.1. This suggests it may be overvalued by 8.4% compared to its current price of around $405.1.
As of Feb 03, 2025, Elevance Health Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $405.1, using a discount rate of 8.5% and terminal growth rate of 3.0%.
As of Feb 03, 2025, Apple Intrinsic Value is $370.3. This suggests it may be overvalued by 8.6% compared to its current price of around $405.1.